Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy-Reference-Cited by-同舟云学术

Association between the genetic polymorphisms of the pharmacokinetics of anthracycline drug and myelosuppression in a patient with breast cancer with anthracycline-based chemotherapy

Published:2021-07 Issue: Volume:276 Page:119392
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Cui Lulu,Huang Jia,Zhan Yongtao,Qiu Ni,Jin Huan,Li Jia,Huang Huiqi,Li Hongsheng

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

2. Anthracycline use for early stage breast cancer in the modern era: a review;Jasra;Curr. Treat. Options in Oncol.,2018

3. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer;Zaheed;Cochrane Database Systematic Rev.,2019

4. Anthracycline could be essential for triple-negative breast cancer: a randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101;Narui;Breast (Edinburgh, Scotland),2019

5. HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15;Paik;J. Natl. Cancer Inst.,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of pharmacogenetics on pharmacokinetics and toxicity of doxorubicin in Egyptian breast cancer patients;Xenobiotica;2024-03-15

2. ANALYSIS OF MYELOSUPPRESSION IN POST-CHEMOTHERAPY BREAST CANCER PATIENTS (A Study at Division of Hematology and Medical Oncology Airlangga University Hospital);2024-02-01

3. “Moderate” adjuvant chemotherapy-induced leukopenia is beneficial for survival of patients with early breast cancer: a retrospective study;BMC Cancer;2023-12-13

4. Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters;Nature Reviews Cancer;2023-09-15

5. Unveiling the Power of Anticancer Drug Screening: A Clinical Case Study Comparing the Effectiveness of Hollow Fiber Assay Microtube Array Membrane (MTAM-HFA) in Breast Cancer Patients;Cancers;2023-05-15